Agilent Technologies Inc (A)
139.45
+1.93
(+1.40%)
USD |
NYSE |
May 03, 16:00
139.51
+0.06
(+0.04%)
After-Hours: 20:00
Agilent Technologies Price to Book Value: 6.604 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 6.604 |
May 02, 2024 | 6.513 |
May 01, 2024 | 6.568 |
April 30, 2024 | 6.49 |
April 29, 2024 | 6.611 |
April 26, 2024 | 6.523 |
April 25, 2024 | 6.458 |
April 24, 2024 | 6.511 |
April 23, 2024 | 6.592 |
April 22, 2024 | 6.342 |
April 19, 2024 | 6.286 |
April 18, 2024 | 6.272 |
April 17, 2024 | 6.372 |
April 16, 2024 | 6.479 |
April 15, 2024 | 6.641 |
April 12, 2024 | 6.665 |
April 11, 2024 | 6.867 |
April 10, 2024 | 6.827 |
April 09, 2024 | 6.981 |
April 08, 2024 | 6.841 |
April 05, 2024 | 6.825 |
April 04, 2024 | 6.694 |
April 03, 2024 | 6.807 |
April 02, 2024 | 6.828 |
April 01, 2024 | 6.894 |
Date | Value |
---|---|
March 28, 2024 | 6.891 |
March 27, 2024 | 6.979 |
March 26, 2024 | 6.839 |
March 25, 2024 | 6.894 |
March 22, 2024 | 6.983 |
March 21, 2024 | 7.044 |
March 20, 2024 | 6.975 |
March 19, 2024 | 6.980 |
March 18, 2024 | 6.919 |
March 15, 2024 | 6.984 |
March 14, 2024 | 6.877 |
March 13, 2024 | 7.001 |
March 12, 2024 | 7.002 |
March 11, 2024 | 6.976 |
March 08, 2024 | 7.003 |
March 07, 2024 | 7.071 |
March 06, 2024 | 6.925 |
March 05, 2024 | 6.836 |
March 04, 2024 | 6.766 |
March 01, 2024 | 6.586 |
February 29, 2024 | 6.505 |
February 28, 2024 | 6.489 |
February 27, 2024 | 6.277 |
February 26, 2024 | 6.227 |
February 23, 2024 | 6.252 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.048
Minimum
Mar 23 2020
10.97
Maximum
Sep 03 2021
6.889
Average
6.891
Median
Mar 28 2024
Price to Book Value Benchmarks
Bio-Rad Laboratories Inc | 0.913 |
Revvity Inc | 1.584 |
Bruker Corp | 7.104 |
Azenta Inc | 1.219 |
Harvard Bioscience Inc | 2.286 |
Price to Book Value Related Metrics
PE Ratio | 33.20 |
PS Ratio | 6.118 |
Price to Free Cash Flow | 24.99 |
Price | 139.45 |
Earnings Yield | 3.01% |
Market Cap | 40.87B |
Operating PE Ratio | 31.50 |
Normalized PE Ratio | 33.20 |